To study the effect of Dexmedetomidine when used as an adjuvant to 0.5% Bupivacaine in Brachial plexus block
Not Applicable
- Conditions
- Health Condition 1: S559- Injury of unspecified blood vesselat forearm levelHealth Condition 2: S614- Open wound of handHealth Condition 3: S615- Open wound of wristHealth Condition 4: S698- Other specified injuries of wrist,hand and finger(s)Health Condition 5: S529- Unspecified fracture of forearmHealth Condition 6: S629- Unspecified fracture of wrist andhand
- Registration Number
- CTRI/2020/11/028887
- Lead Sponsor
- Merin Helen Mathai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA 1 and 2 patients
Patients undergoing forearm and hand surgeries
Exclusion Criteria
Patients with neurological and neuromuscular disorder
Brachial plexus injury
SENSITIVE OR ALLERGIC TO STUDY MEDICATION
Clotting disorder
Local infection
Pregnancy
Patient refusal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Onset and duration of sensory and motor blockTimepoint: Onset and duration of sensory and motor block
- Secondary Outcome Measures
Name Time Method Pulse rate <br/ ><br>Systolic blood pressure <br/ ><br>Diastolic blood pressure <br/ ><br>Mean arterial pressureTimepoint: Baseline parameters <br/ ><br>Every 5 mins from initiation of block upto 30 mins thereafter every 10 mins till the block wean off